机构地区:[1]Institute of Pharmaceutical Science and TechnoloEy, Central Taiwan University of Science and Technology, TaichunE,, Taiwan, China [2]Department of Medical Laboratory Science and Biotechnology, School of Medicine, Taipei Medical University, Taipei, Taiwan, China [3]Department of Health, Taoyuan General Hospital, Taoyuan, Taiwan, China [4]Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan, China
出 处:《Acta Pharmacologica Sinica》2013年第11期1411-1419,共9页中国药理学报(英文版)
摘 要:Aim: To investigate the effects of punicalagin, a polyphenol isolated from Punica granatum, on human U87MG glioma cells in vitro. Methods: The viability of human U87MG glioma cells was evaluated using MTT assay. Cell cycle was detected with flow cytometry analysis. The levels of Bcl-2, cleaved caspase-9, cleaved poly(ADP-ribose) polymerase (PARP), phosphor-AMPK and phosphor-p27 at Thr198 were measured using immunoblot analyses. Caspase-3 activity was determined with spectrophotometer. To determine autopha^Lv, LC3 cleavage and punctate patterns were examined. Results: Punicalagin (1-30 pp=VmL) dose-dependently inhibited the cell viability in association with increased cyclin E level and decreased cyclin B and cyclin A levels. The treatment also induced apoptosis as shown by the cleavage of PARP, activation of caspase-9, and increase of caspase-3 activity in the cells. However, pretreatment of the cells with the pan-caspase inhibitor z-DEVD- fmk (50 pmol/L) did not completely prevent the cell death. On the other hand, punicalagin treatment increased LC3-11 cleavage and caused GFP-LC3-11-stained punctate pattern in the cells. Suppressing autopha~, of cells with chloroquine (1-10 pmol/L) dose- dependently alleviated the cell death caused by punicalagin. Punicalagin (1-30 pp=VmL) also increased the levels phosphor-AMPK and phosphor-p27 at Thr198 in the cells, which were correlated with the induction of autophagic cell death. Conclusion: Punicalagin induces human U87MG glioma cell death through both apoptotic and autophagic pathways.Aim: To investigate the effects of punicalagin, a polyphenol isolated from Punica granatum, on human U87MG glioma cells in vitro. Methods: The viability of human U87MG glioma cells was evaluated using MTT assay. Cell cycle was detected with flow cytometry analysis. The levels of Bcl-2, cleaved caspase-9, cleaved poly(ADP-ribose) polymerase (PARP), phosphor-AMPK and phosphor-p27 at Thr198 were measured using immunoblot analyses. Caspase-3 activity was determined with spectrophotometer. To determine autopha^Lv, LC3 cleavage and punctate patterns were examined. Results: Punicalagin (1-30 pp=VmL) dose-dependently inhibited the cell viability in association with increased cyclin E level and decreased cyclin B and cyclin A levels. The treatment also induced apoptosis as shown by the cleavage of PARP, activation of caspase-9, and increase of caspase-3 activity in the cells. However, pretreatment of the cells with the pan-caspase inhibitor z-DEVD- fmk (50 pmol/L) did not completely prevent the cell death. On the other hand, punicalagin treatment increased LC3-11 cleavage and caused GFP-LC3-11-stained punctate pattern in the cells. Suppressing autopha~, of cells with chloroquine (1-10 pmol/L) dose- dependently alleviated the cell death caused by punicalagin. Punicalagin (1-30 pp=VmL) also increased the levels phosphor-AMPK and phosphor-p27 at Thr198 in the cells, which were correlated with the induction of autophagic cell death. Conclusion: Punicalagin induces human U87MG glioma cell death through both apoptotic and autophagic pathways.
关 键 词:PUNICALAGIN human glioma autophagy apoptosis microtubule-associated protein light chain 3 AMPK P27 z-DEVD-fmk CHLOROQUINE
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...